Artelo Biosciences, Inc.
ARTL· Nasdaq
ARTLArtelo Biosciences, Inc.
Filed Jul 21, 2017 · 10-Q · 51 days after period end · 0001640334-17-001454
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Net Income | -$96.63K | -$5.05K | -$2.50K | -$8.15K |
| EPS Diluted | -$0.01 | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Artelo Biosciences, Inc. · CIK 1621221 · Engraved from SEC EDGAR
ended May 31, 2017 · filed Jul 21, 2017 · 51 d after period end
